Description

In this episode of Clot Clot Who's There, Aviva Schwartz, Director of Education at Vasculearn Network, speaks with Professor Gregory Lip about key anticoagulation and atrial fibrillation data from 2025 and what lies ahead in 2026. The discussion spans post–AF ablation management, holistic AF care, and emerging factor XI inhibitors shaping the future of thrombosis management.

Tune in now and subscribe to Clot, Clot, Who's There? for more expert conversations bridging science, practice, and global perspectives in thrombosis, hemostasis, and vascular medicine.

Chapters:

00:00 Welcome and Introduction

01:59 2025 Trial Highlights: Anticoagulation in Stable CAD and AF Ablation

07:27 High-Risk AF and Holistic Care

10:10 What's Coming in 2026: Factor XI Inhibitors and Upcoming Trials

11:51 Guidelines vs. Real-World Practice